RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
New bacterium in ticks Last year, a man was treated at the Amsterdam Academic Medical Centre (AMC) after being bitten by a tick and becoming infected with a strain of the Borrelia bacterium not previously encountered in